Invention Grant
- Patent Title: Substituted heterocyclic inhibitors of PTPN11
-
Application No.: US16401047Application Date: 2019-05-01
-
Publication No.: US10954243B2Publication Date: 2021-03-23
- Inventor: Philip Jones , Jason Cross , Jason Burke , Timothy Mcafoos , Zhijun Kang
- Applicant: NAVIRE PHARMA, INC.
- Applicant Address: US CA Palo Alto
- Assignee: NAVIRE PHARMA, INC.
- Current Assignee: NAVIRE PHARMA, INC.
- Current Assignee Address: US CA Palo Alto
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C.
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61P35/00 ; C07D519/00
Abstract:
The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.
Public/Granted literature
- US20190389867A1 SUBSTITUTED HETEROCYCLIC INHIBITORS OF PTPN11 Public/Granted day:2019-12-26
Information query
